Recombinant COVID-19 Vaccine (CHO Cell) Included in List of COVID-19 Vaccines for Exportation

Recently, Ministry of Commerce, Ministry of Industry and Information Technology, National Health Commission and the National Medical Products Administration of the People’s Republic of China jointly updated the List of COVID-19 Vaccines for Exportation. The Recombinant COVID-19 Vaccine (CHO Cell) of Zhifei Longcom Biopharmaceutical Co., Ltd (“Zhifei Longcom”), a wholly-owned subsidiary of Chongqing Zhifei Biological Products Co., Ltd (“Zhifei”) has been included in the list.

So far, it has been approved for use (prime or boost) in many countries, such as China, Uzbekistan, Indonesia and Columbia.

Attachment

Source: http://wms.mofcom.gov.cn/article/zcfb/g/202106/20210603135900.shtml